Dana Investment Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $873K | Sell |
2,883
-70
| -2% | -$21.2K | 0.03% | 401 |
|
|
2025
Q1 | $978K | Sell |
2,953
-1,198
| -29% | -$397K | 0.04% | 378 |
|
|
2024
Q4 | $1.28M | Buy |
4,151
+567
| +16% | +$175K | 0.04% | 355 |
|
|
2024
Q3 | $761K | Sell |
3,584
-129
| -3% | -$27.4K | 0.03% | 412 |
|
|
2024
Q2 | $1.04M | Buy |
3,713
+438
| +13% | +$123K | 0.04% | 369 |
|
|
2024
Q1 | $875K | Buy |
3,275
+104
| +3% | +$27.8K | 0.03% | 385 |
|
|
2023
Q4 | $734K | Buy |
3,171
+124
| +4% | +$28.7K | 0.04% | 285 |
|
|
2023
Q3 | $445K | Buy |
+3,047
| New | +$445K | 0.02% | 324 |
|